SEC Form 4 · accession 0001209191-18-057433
Twist Bioscience Corp · TWST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ever Alpha Fund L.P.
10% Owner
Period of report
Nov 2, 2018
Accepted (ET)
Nov 6, 2018 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001581280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 2, 2018 | C | 3,294,961 | — | A | 3,294,961 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series D Preferred StockF2,F1 | — | Nov 2, 2018 | C | 3,294,961 | D | — | — | Common Stock | 3,294,961 | 0 | D |
Explanation of responses
- F1The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.
- F2Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited.